Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response Pathways
- PMID: 26133775
- PMCID: PMC4494107
- DOI: 10.1158/1078-0432.CCR-13-3229
Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response Pathways
Abstract
DNA double-strand breaks are the critical lesions responsible for the majority of ionizing radiation-induced cell killing. Thus, the ability of tumor cells to elicit a DNA damage response following radiation, via activation of DNA repair and cell-cycle checkpoints, promotes radiation resistance and tumor cell survival. Consequently, agents that target these DNA damage response pathways are being developed to overcome radiation resistance. Overall, these agents are effective radiosensitizers; however, their mechanisms of tumor cell selectivity are not fully elucidated. In this review, we focus on the crucial radiation-induced DNA damage responses as well as clinical and translational advances with agents designed to inhibit these responses. Importantly, we describe how synthetic lethality can provide tumor cell-selective radiosensitization by these agents and expand the therapeutic window for DNA damage response-targeted agents used in combination with radiotherapy.
©2015 American Association for Cancer Research.
Conflict of interest statement
M.A. Morgan reports receiving a commercial research grant from AstraZeneca. No potential conflicts of interest were disclosed by the other author.
Figures

Similar articles
-
Targeting base excision repair as a sensitization strategy in radiotherapy.Semin Radiat Oncol. 2010 Oct;20(4):241-9. doi: 10.1016/j.semradonc.2010.05.005. Semin Radiat Oncol. 2010. PMID: 20832016 Review.
-
Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization.Int J Mol Sci. 2016 Jan 14;17(1):102. doi: 10.3390/ijms17010102. Int J Mol Sci. 2016. PMID: 26784176 Free PMC article. Review.
-
Molecular targets that sensitize cancer to radiation killing: From the bench to the bedside.Biomed Pharmacother. 2023 Feb;158:114126. doi: 10.1016/j.biopha.2022.114126. Epub 2022 Dec 13. Biomed Pharmacother. 2023. PMID: 36521246 Review.
-
The novel chemical entity YTR107 inhibits recruitment of nucleophosmin to sites of DNA damage, suppressing repair of DNA double-strand breaks and enhancing radiosensitization.Clin Cancer Res. 2011 Oct 15;17(20):6490-9. doi: 10.1158/1078-0432.CCR-11-1054. Epub 2011 Aug 30. Clin Cancer Res. 2011. PMID: 21878537 Free PMC article.
-
Impact of dietary ingredients on radioprotection and radiosensitization: a comprehensive review.Ann Med. 2024 Dec;56(1):2396558. doi: 10.1080/07853890.2024.2396558. Epub 2024 Sep 25. Ann Med. 2024. PMID: 39320122 Free PMC article. Review.
Cited by
-
Advances in the study of HSP70 inhibitors to enhance the sensitivity of tumor cells to radiotherapy.Front Cell Dev Biol. 2022 Aug 10;10:942828. doi: 10.3389/fcell.2022.942828. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36036010 Free PMC article. Review.
-
LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.Nat Cell Biol. 2020 Oct;22(10):1276-1285. doi: 10.1038/s41556-020-00586-6. Epub 2020 Oct 1. Nat Cell Biol. 2020. PMID: 33005030 Free PMC article.
-
Inhibition of Aurora A enhances radiosensitivity in selected lung cancer cell lines.Respir Res. 2019 Oct 23;20(1):230. doi: 10.1186/s12931-019-1194-8. Respir Res. 2019. PMID: 31647033 Free PMC article.
-
miR-122-5p modulates the radiosensitivity of cervical cancer cells by regulating cell division cycle 25A (CDC25A).FEBS Open Bio. 2019 Nov;9(11):1869-1879. doi: 10.1002/2211-5463.12730. Epub 2019 Sep 29. FEBS Open Bio. 2019. PMID: 31505105 Free PMC article.
-
Effect of CHK1 Inhibition on CPX-351 Cytotoxicity in vitro and ex vivo.Sci Rep. 2019 Mar 5;9(1):3617. doi: 10.1038/s41598-019-40218-0. Sci Rep. 2019. PMID: 30837643 Free PMC article.
References
-
- Wilson WR, Hay MP. Targeting hypoxia in cancer therapy. Nat Rev Cancer. 2011;11:393–410. - PubMed
-
- Baumann M, Krause M, Hill R. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer. 2008;8:545–54. - PubMed
-
- Toulany M, Rodemann HP. Membrane receptor signaling and control of DNA repair after exposure to ionizing radiation. Nuklearmedizin. 2010;49 (Suppl 1):S26–30. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources